Rolando Cannalire
- Molecular Medicine top 5%
- Antibiotic Resistance in Bacteria 8
- Organic Chemistry top 5%
- Quinazolinone synthesis and applications 5
- Infectious Diseases top 5%
- SARS-CoV-2 and COVID-19 Research 5
- Antimicrobial Resistance in Staphylococcus 4
-
- Computational Drug Discovery Methods 6
- Pharmaceutical Science top 5%
-
- Mosquito-borne diseases and control 6
- Malaria Research and Control 5
-
- Phenothiazines and Benzothiazines Synthesis and Activities 6
- Co-authors
- Sveva PellicciaMariateresa GiustinianoGian Cesare TronGiuseppe ManfroniEttore NovellinoLuca SancinetoVioletta CecchettiVincenzo Summa
- Journals
- European Journal of Medicinal Chemistry (6 papers)Journal of Medicinal Chemistry (5 papers)ChemMedChem (3 papers)
- Partner nations
- ItalySpainUnited States
In The Last Decade
Rolando Cannalire
37 papers receiving 1.3k citations
Hit Papers
Peers
Comparison fields: 5 of 83
- Molecular Medicine 128
- Organic Chemistry 612
- Infectious Diseases 393
- Computational Theory and Mathematics 205
- Pharmaceutical Science 64
Countries citing papers authored by Rolando Cannalire
This map shows the geographic impact of Rolando Cannalire's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rolando Cannalire with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rolando Cannalire more than expected).
Fields of papers citing papers by Rolando Cannalire
This network shows the impact of papers produced by Rolando Cannalire. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rolando Cannalire. The network helps show where Rolando Cannalire may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Rolando Cannalire, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 16 | |
| 2 | 2022 | 4 | |
| 3 | 2022 | 2 | |
| 4 | 2022 | 17 | |
| 5 | 2022 | 13 | |
| 6 | 2022 | 4 | |
| 7 | 2021 | 13 | |
| 8 | Visible light photocatalysis in the late-stage functionalization of pharmaceutically relevant compoundsbreakdown → | 2020 | 339 |
| 9 | 2020 | 16 | |
| 10 | 2020 | 16 | |
| 11 | 2019 | 26 | |
| 12 | 2019 | 18 | |
| 13 | 2019 | 13 | |
| 14 | 2018 | 10 | |
| 15 | 2018 | 22 | |
| 16 | 2018 | 48 | |
| 17 | 2017 | 25 | |
| 18 | 2017 | 34 | |
| 19 | 2017 | 30 | |
| 20 | 2016 | 54 |
About Rolando Cannalire
Rolando Cannalire is a scholar working on Molecular Medicine, Infectious Diseases, Organic Chemistry, Virology and Computational Theory and Mathematics, having authored 37 papers that have together received 1.3k indexed citations. Recurring topics across this work include Antibiotic Resistance in Bacteria (8 papers), Computational Drug Discovery Methods (6 papers), Mosquito-borne diseases and control (6 papers), Phenothiazines and Benzothiazines Synthesis and Activities (6 papers), SARS-CoV-2 and COVID-19 Research (5 papers), Quinazolinone synthesis and applications (5 papers), Malaria Research and Control (5 papers) and Antimicrobial Resistance in Staphylococcus (4 papers). The work is most often cited by research in Molecular Medicine (128 citations), Organic Chemistry (612 citations), Infectious Diseases (393 citations), Computational Theory and Mathematics (205 citations) and Pharmaceutical Science (64 citations). Rolando Cannalire has collaborated with scholars based in Italy, Spain and United States. Frequent co-authors include Sveva Pelliccia, Mariateresa Giustiniano, Gian Cesare Tron, Giuseppe Manfroni, Ettore Novellino, Luca Sancineto, Violetta Cecchetti, Vincenzo Summa, Andrea R. Beccari and Carmen Cerchia. Their work appears in journals such as European Journal of Medicinal Chemistry, Journal of Medicinal Chemistry, ChemMedChem, Antiviral Research and ACS Infectious Diseases.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.